news & meetings - latest announcements & happenings | oneFAPvoice

welcome to oneFAPvoice

- a positively charged Familial Adenomatous Polyposis community.
  • join today!
https://media-www.fapvoice.com/wp-content/uploads/2019/01/pivotal-data.jpeg
clinical trials and research

Upcoming events – pivotal data loom for Novavax and Mallinckrodt

  Welcome to your weekly digest of approaching regulatory and clinical readouts. Novavax is up 4% today thanks to topline results from a phase II trial showing that its Nanoflu influenza vaccine caused “vigorous immune responses” to four strains of flu, and that these responses were enhanced when the group’s Matrix-M adjuvant was added to the vaccine. But an even more meaningful event is approaching. Novavax’s lead asset, a vaccine against respiratory syncytial virus, is in phase III, and after its disastrous failure two years ago in a study that was intended to be pivotal this is its last chance. Resvax, also known as RSV F Vaccine since it targets the fusion protein of the virus, crashed out of the Resolve trial, testing it in prevention of moderate to severe RSV-associated lower respiratory tract disease, in mid-2016.  
Jan 4, 2019
https://media-www.fapvoice.com/wp-content/uploads/2018/02/Amy-Mattingly.jpg
people

Bath woman with terminal cancer beats £20,000 fundraising goal in two days

Amy Mattingly’s diagnosis came after her baby boy was born stillborn at 24 weeks. After giving birth to Leo, the 32-year-old went on to have her entire bowel removed and was fitted with an ileostomy bag. However Amy, who lives in Bradford-Upon-Avon but previously lived in Bath, was later given the devastating news that the cancer had spread to her liver. She was told she had just months to live . But now the web designer, originally from Canada, has successfully raised more than £20,000 which will allow her to undergo a new form of radiotherapy which could extend her life. The treatment, Selective Internal Radiation Therapy, involves injecting microbeads of radiation directly into the liver. It is not currently available on the NHS and costs around £20,000.
Jan 25, 2018

CGA Annual Meeting

Nov 3, 2019

Annual DTRF Patient Meeting

Sep 21, 2019

Undy Run/Walk

Mar 31, 2019

RARE on the Road

Mar 30, 2019

Rare Disease Day – Home

Feb 28, 2019

Rare Disease Week on Capitol Hill

Feb 24, 2019
view all (13)